Aster Dm Healthcare Share Price
Sector: Healthcare Facilities
568.30 -18.15 (-3.09%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
564.00
Today’s High
586.45
52 Week Low
315.50
52 Week High
609.00
567.85 -18.10 (-3.09%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
564.00
Today’s High
587.70
52 Week Low
315.50
52 Week High
609.50
Key Metrics
- Market Cap (In Cr) 29444.82
- Beta 1.02
- Div. Yield (%) 0.88
- P/B 8.25
- TTM P/E 80.69
- Peg Ratio -0.32
- Sector P/E 23.4
- D/E 0.01
- Open Price 581.1
- Prev Close 586.45
Aster Dm Healthcare Analysis
Price Analysis
-
1 Week-0.33%
-
3 Months32.23%
-
6 Month16.29%
-
YTD10.49%
-
1 Year58.57%
Risk Meter
- 31% Low risk
- 31% Moderate risk
- 31% Balanced Risk
- 31% High risk
- 31% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 5
- 5
- Buy
- 3
- 3
- 3
- 3
- Hold
- 1
- 1
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 8
- 8
- 8
- 8
Aster Dm Healthcare News
Shareholdings moves in Q4: Pledging peril hits smallcaps, raising investor fears
3 min read . 15 May 2025Stocks to watch: Wipro, IndusInd Bank, Swiggy, IREDA among shares in focus today
2 min read . 16 Apr 2025These 5 small-cap stocks have higher yields than bank FD, PPF interest rate
2 min read . 08 Apr 2025Aster Dm Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 4138.46
- Selling/ General/ Admin Expenses Total
- 760.39
- Depreciation/ Amortization
- 248.84
- Other Operating Expenses Total
- 754.04
- Total Operating Expense
- 3672.91
- Operating Income
- 465.55
- Net Income Before Taxes
- 471.06
- Net Income
- 5377.83
- Diluted Normalized EPS
- 6.87
- Period
- 2025
- Total Assets
- 6606.38
- Total Liabilities
- 3178.31
- Total Equity
- 3428.07
- Tangible Book Valueper Share Common Eq
- 62.9
- Period
- 2025
- Cashfrom Operating Activities
- 425.05
- Cashfrom Investing Activities
- 6014.87
- Cashfrom Financing Activities
- -6357.81
- Net Changein Cash
- 82.36
- Period
- 2024
- Total Revenue
- 3698.9
- Selling/ General/ Admin Expenses Total
- 1252.62
- Depreciation/ Amortization
- 219.97
- Other Operating Expenses Total
- 51.67
- Total Operating Expense
- 3340.69
- Operating Income
- 358.21
- Net Income Before Taxes
- 261.19
- Net Income
- 129.28
- Diluted Normalized EPS
- 2.46
- Period
- 2024
- Total Assets
- 17991.31
- Total Liabilities
- 13431.52
- Total Equity
- 4559.79
- Tangible Book Valueper Share Common Eq
- 85.67
- Period
- 2024
- Cashfrom Operating Activities
- 157.81
- Cashfrom Investing Activities
- -884.65
- Cashfrom Financing Activities
- 1052.83
- Net Changein Cash
- 332.39
- Period
- 2023
- Total Revenue
- 2994.05
- Selling/ General/ Admin Expenses Total
- 1003.09
- Depreciation/ Amortization
- 192.04
- Other Operating Expenses Total
- 49.71
- Total Operating Expense
- 2737.01
- Operating Income
- 257.04
- Net Income Before Taxes
- 195.46
- Net Income
- 424.91
- Diluted Normalized EPS
- 2.19
- Period
- 2023
- Total Assets
- 14881.2
- Total Liabilities
- 10433.13
- Total Equity
- 4448.07
- Tangible Book Valueper Share Common Eq
- 58.72
- Period
- 2023
- Cashfrom Operating Activities
- 1833.98
- Cashfrom Investing Activities
- -971.88
- Cashfrom Financing Activities
- -817.39
- Net Changein Cash
- 65.74
- Period
- 2022
- Total Revenue
- 10253.28
- Selling/ General/ Admin Expenses Total
- 4491.38
- Depreciation/ Amortization
- 640.58
- Other Operating Expenses Total
- 450.57
- Total Operating Expense
- 9409.35
- Operating Income
- 843.93
- Net Income Before Taxes
- 636.85
- Net Income
- 525.99
- Diluted Normalized EPS
- 10.57
- Period
- 2022
- Total Assets
- 12546.24
- Total Liabilities
- 8592.83
- Total Equity
- 3953.41
- Tangible Book Valueper Share Common Eq
- 52.04
- Period
- 2022
- Cashfrom Operating Activities
- 1313.46
- Cashfrom Investing Activities
- -570.48
- Cashfrom Financing Activities
- -685.42
- Net Changein Cash
- 64.78
- Period
- 2021
- Total Revenue
- 8608.43
- Selling/ General/ Admin Expenses Total
- 3807.17
- Depreciation/ Amortization
- 617.57
- Other Operating Expenses Total
- 436.12
- Total Operating Expense
- 8160.92
- Operating Income
- 447.51
- Net Income Before Taxes
- 205.05
- Net Income
- 147.74
- Diluted Normalized EPS
- 2.97
- Period
- 2021
- Total Assets
- 11643.46
- Total Liabilities
- 8271
- Total Equity
- 3372.46
- Tangible Book Valueper Share Common Eq
- 41.65
- Period
- 2021
- Cashfrom Operating Activities
- 1569.12
- Cashfrom Investing Activities
- -330.3
- Cashfrom Financing Activities
- -1116.13
- Net Changein Cash
- 119.9
- Period
- 2020
- Total Revenue
- 8651.88
- Selling/ General/ Admin Expenses Total
- 3849.46
- Depreciation/ Amortization
- 585.94
- Other Operating Expenses Total
- 204.31
- Total Operating Expense
- 7999.28
- Operating Income
- 652.6
- Net Income Before Taxes
- 330.04
- Net Income
- 276.61
- Diluted Normalized EPS
- 5.97
- Period
- 2020
- Total Assets
- 12437.84
- Total Liabilities
- 9165.7
- Total Equity
- 3272.14
- Tangible Book Valueper Share Common Eq
- 39.78
- Period
- 2020
- Cashfrom Operating Activities
- 1223.25
- Cashfrom Investing Activities
- -667.28
- Cashfrom Financing Activities
- -674.8
- Net Changein Cash
- -109.92
- Period
- 2019
- Total Revenue
- 7962.71
- Selling/ General/ Admin Expenses Total
- 3525.97
- Depreciation/ Amortization
- 306.47
- Other Operating Expenses Total
- 449.9
- Total Operating Expense
- 7405.45
- Operating Income
- 557.26
- Net Income Before Taxes
- 410.25
- Net Income
- 333.11
- Diluted Normalized EPS
- 6.62
- Period
- 2019
- Total Assets
- 8936.41
- Total Liabilities
- 5722.65
- Total Equity
- 3213.76
- Tangible Book Valueper Share Common Eq
- 44.48
- Period
- 2019
- Cashfrom Operating Activities
- 583.55
- Cashfrom Investing Activities
- -691.54
- Cashfrom Financing Activities
- 134.42
- Net Changein Cash
- 32.93
- Period
- 2025-03-31
- Period
- 2025-03-31
- Total Assets
- 6606.38
- Total Liabilities
- 3178.31
- Total Equity
- 3428.07
- Tangible Book Valueper Share Common Eq
- 62.9
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 425.05
- Cashfrom Investing Activities
- 6014.87
- Cashfrom Financing Activities
- -6357.81
- Net Changein Cash
- 82.36
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Period
- 2024-09-30
- Total Assets
- 6687.6
- Total Liabilities
- 3252.13
- Total Equity
- 3435.47
- Tangible Book Valueper Share Common Eq
- 63.05
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 201.59
- Cashfrom Investing Activities
- 6773.52
- Cashfrom Financing Activities
- -6142.7
- Net Changein Cash
- 832.34
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Period
- 2024-03-31
- Total Assets
- 17991.31
- Total Liabilities
- 13431.52
- Total Equity
- 4559.79
- Tangible Book Valueper Share Common Eq
- 85.67
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 157.81
- Cashfrom Investing Activities
- -884.65
- Cashfrom Financing Activities
- 1052.83
- Net Changein Cash
- 332.39
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Aster Dm Healthcare Technical
Moving Average
SMA
- 5 Day568.71
- 10 Day569.71
- 20 Day563.66
- 50 Day534.03
- 100 Day489.91
- 300 Day468.51
Aster Dm Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Narayana Hrudayalaya
- 1902.6
- -35.85
- -1.85
- 1957.2
- 1171.35
- 39033.72
- Global Health
- 1183.95
- -33.3
- -2.74
- 1388.65
- 936.05
- 31766.78
- Aster Dm Healthcare
- 568.3
- -18.15
- -3.09
- 609
- 315.5
- 29444.82
- Krishna Instit Of Medical Scienc
- 659.95
- -19.25
- -2.83
- 707.5
- 401.93
- 26378.04
- Dr. Lal Pathlabs
- 2920
- -29.75
- -1.01
- 3645
- 2295.1
- 24475.31
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Narayana Hrudayalaya
- 49.33
- 10.83
- 25.11
- 11.8
- Global Health
- 63.06
- 9.65
- 14.18
- 11.38
- Aster Dm Healthcare
- 85.32
- 8.52
- 6.16
- 4.98
- Krishna Instit Of Medical Scienc
- 72.22
- 12.72
- 21.99
- 15.55
- Dr. Lal Pathlabs
- 50.29
- 11.31
- 21.87
- 16.8
Aster Dm Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 17.04%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 20-May-25
- Audited Results & Final Dividend
- 31-Jan-25
- Quarterly Results & Interim Dividend
- 23-Oct-24
- Quarterly Results
- 31-Jul-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 12-Apr-24
- Interim Dividend & Special Dividend
- 08-Feb-24
- Quarterly Results
- 14-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 25-May-23
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 31-Dec-24
- 02-Dec-24
- POM
- 24-Jan-24
- 26-Dec-23
- POM
- 31-Aug-23
- 25-May-23
- AGM
- 10-Apr-23
- 09-Mar-23
- POM
- 25-Aug-22
- 24-May-22
- AGM
- 22-Mar-22
- 16-Feb-22
- POM
- 13-Aug-21
- 24-Jun-21
- AGM
- -
- 28-May-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 20-May-25
- -
- -
- 1
- 27-Jan-25
- 10-Feb-25
- 10-Feb-25
- 4
- 28-May-24
- 22-Aug-24
- 22-Aug-24
- 2
- 05-Apr-24
- 23-Apr-24
- 23-Apr-24
- 118


